Purchases and Sales Made in Q1 2023 in Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN) during Q1 2023. The information is specifically focused on institutions that hold shares of Day One Biopharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Oct 07, 2024
Q1 2023
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-104K- 20.49% |
$1.32M - $2.43M
|
402K
$3.9M
|
|
May 12, 2023
Q1 2023
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-104K- 20.49% |
$1.32M - $2.43M
|
402K
$3.9M
|
|
May 12, 2023
Q1 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-177K- 7.26% |
$2.25M - $4.14M
|
2.26M
$21.9M
|
|
May 15, 2023
Q1 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-177K- 29.43% |
$2.26M - $4.14M
|
424K
$4.12M
|
|
May 15, 2023
Q1 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-200K- 8.13% |
$2.55M - $4.68M
|
2.26M
$21.9M
|
|
May 15, 2023
Q1 2023
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-403K- 74.01% |
$5.14M - $9.43M
|
142K
$1.37M
|
|
May 15, 2023
Q1 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-462KClosed |
$5.89M - $10.8M
|
0
$0
|
|
May 15, 2023
Q1 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-518K- 23.73% |
$6.6M - $12.1M
|
1.66M
$16.1M
|
|
Dec 13, 2023
Q1 2023
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-535K- 27.67% |
$6.83M - $12.5M
|
1.4M
$13.6M
|
|
May 15, 2023
Q1 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-2.56M- 77.58% |
$32.6M - $59.9M
|
740K
$7.18M
|